Institute of Medicinal Biotechnology, Peking Union Medical College & Chinese Academy of Medical Sciences, No. 1, Tian Tan Xi Li, 100050, Beijing, PR China.
China National Institutes for Food and Drug Control, No. 2, Tian Tan Xi Li, 100050, Beijing, PR China.
J Pharm Biomed Anal. 2021 Jul 15;201:114099. doi: 10.1016/j.jpba.2021.114099. Epub 2021 Apr 24.
The complex industrial production process of amino acids (AAs) leads to the existence of a certain amount of impurities in Compound Amino Acid Injection (6AA). It is difficult to obtain its comprehensive and systematic impurity profile using conventional ultraviolet (UV) detectors due to lack of a suitable chromophore in the structures of AAs and their impurities. In our study, a universal ion-pair high performance liquid chromatography (HPLC) method combined with high resolution mass spectrometer (HRMS) and charged aerosol detection (CAD) was developed to identify and determine the content of impurities in Compound Amino Acid Injection (6AA), respectively. After optimizing the content of trifluoroacetic acid (TFA) and heptafluorobutyric acid (HFBA) in the mobile phase on a C18 AQ column, HPLC-CAD method was developed and nine unknown impurities were detected. These impurities were successfully identified using HPLC coupled with orbitrap mass spectrometry and confirmed with their reference substances. The CAD parameters setting was optimized to improve the sensitivity and linearity of the methods before the developed method was validated. The results of validation reflected that the limit of detection (LOD) was approximately 2 ng (corresponding to approximately 0.02 % of L-isoleucine in injection). Under the optimized power function value (PFV) of CAD, the linear range of each impurity was 1 ∼ 200 μg mL (the linear range of one of the impurities with higher content was 2 ∼ 400 μg mL) with coefficients of determination (R) greater than 0.998. The recovery rates for nine impurities were 93.37 % ∼ 110.23 %. This study made full use of the qualitative functions of HRMS and the versatility of CAD, revealing possible impurities in the 6AA injection, which could provide reference for the safety research of it.
氨基酸(AAs)的复杂工业生产过程导致复方氨基酸注射液(6AA)中存在一定量的杂质。由于 AAs 及其杂质的结构中缺乏合适的生色团,因此很难使用常规的紫外(UV)检测器获得其全面和系统的杂质概况。在我们的研究中,开发了一种通用的离子对高效液相色谱(HPLC)方法,结合高分辨率质谱(HRMS)和带电气溶胶检测(CAD),分别用于鉴定和测定复方氨基酸注射液(6AA)中的杂质含量。在 C18AQ 柱上优化流动相中三氟乙酸(TFA)和七氟丁酸(HFBA)的含量后,开发了 HPLC-CAD 方法,并检测到 9 种未知杂质。使用 HPLC 结合轨道阱质谱成功鉴定了这些杂质,并使用其对照品进行了确认。在对开发的方法进行验证之前,通过优化 CAD 参数设置来提高方法的灵敏度和线性度。验证结果反映出检测限(LOD)约为 2ng(相当于注射液中 L-异亮氨酸的约 0.02%)。在 CAD 的优化幂函数值(PFV)下,每种杂质的线性范围为 1∼200μg mL(其中一种杂质含量较高的线性范围为 2∼400μg mL),相关系数(R)大于 0.998。9 种杂质的回收率为 93.37%∼110.23%。本研究充分利用了 HRMS 的定性功能和 CAD 的通用性,揭示了 6AA 注射液中可能存在的杂质,为其安全性研究提供了参考。